- Zyprexa news are updated once a hour
- We deliver news from more than 500 sources on Zyprexa
NewsAdvertisers: |
Medicare plan may mean big drug profits... An AstraZeneca spokesperson questioned the study's methodology, saying the profit estimate for Seroquel, a schizophrenia medication, was too high. AstraZeneca gave no alternate figures. A GlaxoSmithKline spokesperson wouldn't discuss projected earnings for Lamictal, a treatment for bipolar disorder. A spokesperson for Lilly said the company expected only a "modest short-term benefit to sales" for Lilly's earnings per share could rise by 6 percent in 2006 just by escaping the rebates, the Prudential study estimates. With U.S. sales of $2.76 billion in 2005, Seroquel's increased Medicare profit could boost AstraZeneca's earnings per share by 8 percent, the report found. Company policy prohibits Prudential analysts from discussing reports with non-clients, company spokesman Jim Gorman said. Rising revenue
Tony Butler, managing director and pharmaceutical analyst at Lehman Bros., an investment bank in New York, agreed with the report that Medicare probably would have higher drug prices than Medicaid. Butler estimated the sales windfall for drug companies under Medicar... Pharmas May Rake In Extra Billions with Medicare Drug Plan... An AstraZeneca spokesperson questioned the study's methodology, saying the profit estimate for Seroquel, a schizophrenia medication, was too high. AstraZeneca gave no alternate figures. A GlaxoSmithKline spokesperson wouldn't discuss projected earnings for Lamictal, a treatment for bipolar disorder. A spokesperson for Lilly said the company expected only a "modest short-term benefit to sales" for With US sales of $2.76 billion in 2005, Seroquel's increased Medicare profit could boost AstraZeneca's earnings per share by 8 percent, the report found. Company policy prohibits Prudential analysts from discussing reports with non-clients, said company spokesman Jim Gorman. Drafted by Drug Industry Lobbyists?
Tony Butler, managing director and pharmaceutical an... Medicare | 10-Year Cost Projection for Medicare Drug Benefit Drops ...... The segment includes comments from Robert Laszewski, political analyst and health consultant for the insurance industry (Tong, "Marketplace," APM, 2/2). The complete segment is available online in RealPlayer. In addition, PBS' "NewsHour with Jim Lehrer" on Thursday reported on the benefit. The segment includes comments from Mary Grealy, president of the Healthcare Leadership Council, and Ron Pollack, executive director of Families USA (Suarez, "NewsHour with Jim Lehrer," PBS, 2/2). The complete transcript is available online. The complete segment is available online in RealPlayer. ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ..... About Us Privacy Policy Help Site Map Kaisernetwork.org is a free service of the Henry J. Kaiser Family Foundation. ... 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news |
| Medicine | Health and Fitness |